Trials / Terminated
TerminatedNCT01068119
Same-Day Discharge After Coronary Percutaneous Transluminal Coronary Angioplasty (PTCA)
Feasibility and Safety of Same-Day Discharge of Troponin Negative Patients After Coronary PTCA Via the Transfemoral Approach
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 57 (actual)
- Sponsor
- Piedmont Healthcare · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Same day discharge is safe and feasible in selected troponin negative patients undergoing coronary planned percutaneous coronary intervention (PCI) or ad hoc PCI via the transfemoral approach.
Detailed description
The feasibility and safety of same day discharge post PCI will be examined. Study data will be compared to national registries and national or regional databases of PCI in Troponin negative patients with overnight stay. As part of the registry we will also assess compliance with dual antiplatelet therapy at six months and at 1 year and will record any reasons for premature discontinuation as well as any associated adverse events.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Same-day discharge | Patients identified as clinically stable are discharged home the same day as the PCI procedure with telephone follow-up at 12 hr, 24 hr, 3, 30, 180 and 365 days post procedure. |
Timeline
- Start date
- 2010-02-01
- Primary completion
- 2011-08-01
- Completion
- 2012-03-01
- First posted
- 2010-02-12
- Last updated
- 2013-09-23
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01068119. Inclusion in this directory is not an endorsement.